Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02661620 · ClinicalTrials.gov registry record
REDAPT Retrospective-Prospective Modular Stem Study
A clinical trial, sponsored by Smith & Nephew.
- Terminated
- Registry status
- 140
- Enrollment target
NCT02661620: Clinical Trial study, sponsored by Smith & Nephew.
NCT02661620 is a clinical trial that was terminated before completion, run by Smith & Nephew. The registered enrollment target is 140 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02661620 was terminated before completion, sponsored by Smith & Nephew.
- TERMINATED
- Registry status
- 140 participants
- Enrollment target
Study Summary
A Retrospective-Prospective Study of REDAPT Revision Femoral System Modular Stem is a post-market, retrospective-prospective, multi-center, single arm, consecutive series study design to provide data on the post market performance and safety of the study device. The study will collect retrospective data from medical records review and prospective data from observations data at 5 and 10 postoperatively clinical visits. There will also be a 7.5 year telephone follow up contact to assess for device status and adverse events.
Primary Outcome
Listing of stem implant status at 5 years to analyze stem survival rate
Interventions
- DEVICE REDAPT Revision Femoral System modular stem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2016-02 |
| Est. Completion | 2020-04-16 |
Why NCT02661620 stopped before completion
NCT02661620 is an observational study that tracks outcomes without assigning an intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which REDAPT Revision Femoral System modular stem is the first listed.
NCT02661620 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02661620 about?
NCT02661620 is a clinical study titled "REDAPT Retrospective-Prospective Modular Stem Study". A Retrospective-Prospective Study of REDAPT Revision Femoral System Modular Stem is a post-market, retrospective-prospective, multi-center, single arm, consecutive series study design to provide data on the post market performance and safety of the study device. The study will collect retrospective ...
What is the current status of trial NCT02661620?
This trial is currently terminated. The enrollment target is 140 participants. The study started on 2016-02. Estimated completion is 2020-04-16.
What interventions are being tested in trial NCT02661620?
The interventions under investigation include: REDAPT Revision Femoral System modular stem (DEVICE).
Who is sponsoring clinical trial NCT02661620?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia